Apellis Pharmaceuticals buy phonebroker
Start price
18.01.18
/
50%
€17.99
Target price
22.01.18
€18.94
Performance (%)
6.26%
End price
22.01.18
€19.11
Summary
This prediction ended on 22.01.18 with a price of €19.11. With a performance of 6.26%, the BUY prediction by phonebroker for Apellis Pharmaceuticals closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |